Isabel S. Naarmann-De Vries

Isabel S. Naarmann-De Vries

Auto-generated profile, based on publicly available information

Isabel S. Naarmann-De Vries

Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), University Hospital Heidelberg , Im Neuenheimer Feld 669, 69120 Heidelberg

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
EBEtienne Boileau
Etienne Boileau
XLXue Li
Xue Li
IVIsabel S Naarmann-De Vries
Isabel S Naarmann-De Vries
CBChristian Becker
Christian Becker
RCRamona Casper
Ramona Casper
CDChristoph Dieterich
Christoph Dieterich
We introduce Single-cell Nanopore Spatial Transcriptomics (scNaST), a software suite to facilitate the analysis of spatial gene expression from second- and third-generation sequencing, allowing to generate a full-length near-single-cell transcriptional landscape of the tissue microenvironment. Taking advantage of the Visium Spatial platform, we adapted a strategy recently developed to assign barcodes to long-read single-cell sequencing data for spatial capture technology. Here, we demonstrate our workflow using four short axis sections of the mouse heart following myocardial infarction. We constructed a de novo transcriptome using long-read data, and successfully assigned 19,794 transcript isoforms in total, including clinically-relevant, but yet uncharacterized modes of transcription, such as intron retention or antisense overlapping transcription. We showed a higher transcriptome complexity in the healthy regions, and identified intron retention as a mode of transcription associated with the infarct area. Our data revealed a clear regional isoform switching among differentially used transcripts for genes involved in cardiac muscle contraction and tissue morphogenesis. Molecular signatures involved in cardiac remodeling integrated with morphological context may support the development of new therapeutics towards the treatment of heart failure and the reduction of cardiac complications.

7 August 2019 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
AUAlexey Uvarovskii
Alexey Uvarovskii
IVIsabel S. Naarmann-De Vries
Isabel S. Naarmann-De Vries
CDChristoph Dieterich
Christoph Dieterich
Massively parallel RNA sequencing (RNA-seq) in combination with metabolic labeling has become the de facto standard approach to study alterations in RNA transcription, processing or decay. Regardless of advances in the experimental protocols and techniques, every experimentalist needs to specify the key aspects of experimental design: For example, which protocol should be used (biochemical separation vs. nucleotide conversion) and what is the optimal labeling time? In this work, we provide approximate answers to these questions using the asymptotic theory of optimal design. Specifically, we investigate, how the variance of degradation rate estimates depends on the time and derive the optimal time for any given degradation rate. Subsequently, we show that an increase in sample numbers should be preferred over an increase in sequencing depth. Lastly, we provide some guidance on use cases when laborious biochemical separation outcompetes recent nucleotide conversion based methods (such as SLAMseq) and show, how inefficient conversion influences the precision of estimates. Code and documentation can be found at https://github.com/dieterich-lab/DesignMetabolicRNAlabeling. Massively parallel RNA sequencing (RNA-seq) in combination with metabolic labeling has become the de facto standard approach to study alterations in RNA transcription, processing or decay. In our manuscript, we address several key aspects of experimental design: 1) The optimal labeling time, 2) the number of replicate samples over sequencing depth and 3) the choice of experimental protocol. We provide approximate answers to these questions using asymptotic theory of optimal design.

18 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
IVIsabel S. Naarman-De Vries
Isabel S. Naarman-De Vries
EGEnio Gjerga
Enio Gjerga
CGCatharina L.A. Gandor
Catharina L.A. Gandor
CDChristoph Dieterich
Christoph Dieterich
ONT long-read sequencing provides real-time monitoring and controlling of individual nanopores. Adaptive sampling enriches or depletes specific sequences in Nanopore DNA sequencing, but was not applicable to direct sequencing of RNA so far. Here, we identify essential parameter settings for direct RNA sequencing (DRS). We demonstrate the superior performance of depletion over enrichment and show that adaptive sampling efficiently depletes specific transcripts in transcriptome-wide sequencing applications. Specifically, we applied our adaptive sampling approach to polyA+ RNA samples from human cardiomyocytes and mouse whole heart tissue. Herein, we show more than 2.5-fold depletion of highly abundant mitochondrial-encoded transcripts that in normal sequencing account for up to 40% of sequenced bases in heart tissue samples.

26 September 2025 in Bioinformatics
Verified
Journal Article
Open access
ACAdrian Chan
Adrian Chan
IVIsabel S Naarmann-De Vries
Isabel S Naarmann-De Vries
CDChristoph Dieterich
Christoph Dieterich
Summary: The development of third-generation sequencing technologies enables the detection of RNA modifications at single-molecule resolution. Specifically for direct RNA sequencing on the ONT platform, we have previously developed an m6A detection algorithm called mAFiA. Here, we present the updated method, now covering all 18 DRACH m6A contexts as well as the identification of pseudouridine sites (Ψ). Our modification level predictions compare favorably with orthogonal methods and respond to knockdown or knock out of writer proteins. The simultaneous detection of multiple modifications on a single RNA molecule opens up the possibility to study cross-modification interactions. Availability and implementation: Ψ-co-mAFiA is available at https://github.com/dieterich-lab/psi-co-mAFiA and licensed under GPLv3.0. An archived version of the software is available on Zenodo at https://doi.org/10.5281/zenodo.16797676.

27 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AWAlexander N. Wirth
Alexander N. Wirth
IVIsabel S. Naarmann-De Vries
Isabel S. Naarmann-De Vries
APAnne M. Pinnen
Anne M. Pinnen
AGAiswarya Gopal
Aiswarya Gopal
ARAnna Righetti
Anna Righetti
JPJirka Peschek
Jirka Peschek
SUMMARY: RNA is continuously exposed to damage during physiological metabolism and stress, yet cellular responses to RNA damage remain less understood than DNA repair pathways. RNA strand breaks are particularly deleterious because they generate chemically incompatible RNA ends. Eukaryotic tRNA ligases have been implicated in RNA processing and repair, but whether they function as general RNA repair enzymes remains unresolved. Here, we show that the evolutionarily divergent tRNA ligases, human RTCB and fungal Trl1, mediate RNA break repair (RBR) targeting ribosomes and other ribonucleoprotein (RNP) complexes. Using direct RNA nanopore sequencing, we map these repair events at nucleotide resolution, demonstrating that tRNA ligases repair breaks in ribosomal RNA and restore translational activity of repaired ribosomes. We further identify repair across additional structured cellular RNAs. We show that loss of RBR activity leads to RNA fragmentation in human cells and impairs cell viability upon oxidative stress. Together, these findings uncover a broader role for eukaryotic tRNA ligases in repairing RNA breaks and maintaining transcriptome integrity.

20 October 2025 in bioRxiv
Verified
Preprint
Open access
MPMichael Piechotta
Michael Piechotta
WGWei Guo
Wei Guo
IVIsabel S. Naarmann-De Vries
Isabel S. Naarmann-De Vries
FKFelix Kallenborn
Felix Kallenborn
Francesca TuortoFrancesca Tuorto
Francesca Tuorto
CDChristoph Dieterich
Christoph Dieterich
Transfer RNAs (tRNAs) are essential for protein synthesis and are extensively modified to ensure their structure and function. Direct RNA sequencing with Oxford Nanopore Technologies enables positional modification analysis but is challenged by tRNAs’ short length, redundancy, and dense modifications. We present QutRNA2, a scalable workflow featuring GPU-accelerated local alignment, statistical filtering, pairwise error profile comparison, and customizable visualization. Achieving up to 25-fold speed gains over CPU methods, QutRNA2 identifies enzyme-dependent modifications in nuclear- and mitochondrial-encoded tRNAs, demonstrated in human and mouse samples. This open-source solution provides a comprehensive, multiplexing-compatible framework for tRNA analysis, addressing a key gap in current tools.